Directorio de personas
Xavier Matias-Guiu Guia

Xavier Matias-Guiu Guia

Grado: Doctor/a

973 705 340
fjmatiasguiu.lleida.ics(ELIMINAR)@gencat.cat

ResearcherID: http://www.researcherid.com/rid/C-3039-2009

Grupos

Publicaciones

  • Domingo, P; Vidal, F; Domingo, JC; Veloso, S; Sambeat, MA; Torres, F; Sirvent, JJ; Vendrell, J; Matias-Guiu, X; Richart, C

    Tumour necrosis factor alpha in fat redistribution syndromes associated with combination antiretroviral therapy in HIV-1-infected patients: potential role in subcutaneous adipocyte apoptosis

    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION 35 771-780. .

    [doi:10.1111/j.1365-2362.2005.01576.x]

  • Pallares, J; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Palacios, J; Prat, J; Matias-Guiu, X

    Survivin expression in endometrial carcinoma - a tissue microarray study with correlation with PTEN and STaT-3

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 24 247-253. .

    [doi:10.1097/01.pgp.0000163849.37129.d4]

  • Pallares J; Martínez-Guitarte JL; Dolcet X; Llobet D; Rue M; Palacios J; Prat J; Matias-Guiu X

    Survivin expression in endometrial carcinoma: a tissue microarray study with correlation with PTEN and STAT-3.

    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY 24 247-253. .

  • Dolcet, X; Llobet, D; Pallares, J; Rue, M; Comella, JX; Matias-Guiu, X

    FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis.

    LABORATORY INVESTIGATION 85 885-894. .

    [doi:10.1038/labinvest.3700286]

  • Velasco A; Palomar-Asenjo V; Gañan L; Catasus L; Llecha N; Panizo A; Palomar-Garcia V; Quer M; Matias-Guiu X

    Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma: description of one novel germline mutation.

    Diagnostic Molecular Pathology 14 109-114. .

  • Velasco, A; Palomar-Asenjo, V; Ganan, L; Catasus, L; Llecha, N; Panizo, A; Palomar-Garcia, V; Quer, M; Matias-Guiu, X

    Mutation analysis of the SDHD gene in four kindreds with familial paraganglioma - Description of one novel germline mutation

    Diagnostic Molecular Pathology 14 109-114. .

    [doi:10.1097/01.pas.0000158987.07907.7e]

  • Irving, JA; Catasus, L; Gallardo, A; Bussaglia, E; Romero, M; Matias-Guiu, X; Prat, J

    Synchronous endometrioid carcinomas of the uterine corpus and ovary: alterations in the beta-catenin (CTNNB1) pathway are associated with independent primary tumors and favorable prognosis

    HUMAN PATHOLOGY 36 605-619. .

    [doi:10.1016/j.humpath.2005.03.005]

  • Dolcet, X; Llobet, D; Pallares, J; Matias-Guiu, X

    NF-kB in development and progression of human cancer.

    VIRCHOWS ARCHIV 446 475-482. .

    [doi:10.1007/s00428-005-1264-9]

  • Pallares, J; Bussaglia, E; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Sanchez-Verde, L; Palacios, J; Prat, J; Matias-Guiu, X

    Immunohistochemical analysis of PTEN in endometrial carcinoma: a tissue microarray study with a comparison of four commercial antibodies in correlation with molecular abnormalities.

    Modern Pathology 18 719-727. .

    [doi:10.1038/modpathol.3800347]

  • Isidro, ML; Diaz, PI; Matias-Guiu, X; Cordido, F

    Acromegaly due to a growth hormone-releasing hormone-secreting intracranial gangliocytoma

    Journal Of Endocrinological Investigation 28 162-165. .

  • Pallares, J; Martinez-Guitarte, JL; Dolcet, X; Llobet, D; Rue, M; Palacios, J; Prat, J; Matias-Guiu, X

    Abnormalities in the NF-kappaB family and related proteins in endometrial carcinoma.

    JOURNAL OF PATHOLOGY 204 569-577. .

    [doi:10.1002/path.1666]

  • Vidal, D; Matias-Guiu, X; Alomar, A

    Open study of the efficacy and mechanism of action of topical imiquimod in basal cell carcinoma

    CLINICAL AND EXPERIMENTAL DERMATOLOGY 29 518-525. .

    [doi:10.1111/j.1365-2230.2004.01601.x]

Proyectos

  • Unravelling the molecular and phenotypic complexity of endometriosis through new models and omics integration: towards a personalized clinical management
  • Homologous recombination deficiency in high-grade endometrial cancers. Biomarkers and impact of intratumor heterogeneity.
  • EPH Receptor Signaling in Endometrial Cancer
  • Ajuts per a la contractació de personal investigador novell (FI)
  • Personalized Immunotherapy for Endometrial Cancer; Acronym: ExCITE (Endometrial Cancer Immunotherapy)
  • "Multi-Omics data for Cancer Research and the Development of New Diagnostics and Therapies"
  • EFFICACY: Nuevas estrategias para incrementar efectividad de los tratamientos con ABTL0812
  • Perfiles epigenéticos asociados a patrones de metastasis en cáncer de endometrio
  • CONTRACTES D'INCORPORACIO DE CIENTIFICS I TECNOLEGS: INCORPORACIO D'UNA DOCTORA PER A L'ACCIO ANTITUMORAL DELS CANNABINOIDES EN EL CARCINOMA D'ENDOMETRI
  • DISCOVERY, VALIDATION AND IMPLEMENTATION OF BIOMARKERS FOR PRECISION ONCOLOGY
  • Desarrollo de nuevas aproximaciones en el manejo individualizado de pacientes con cancer ginecológico (PREDICTGYN)
  • VALIDACION DE ANEXINA 2 COMO PREDICTOR DE RECIDIVA EN EL CANCER DE ENDOMETRIO. DISEÑO DE NUEVAS ESTRATEGIAS TERAPEUTICAS. ANXARECU